Who We Are
LEO Pharma Inc. is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology. LEO Pharma products have been available in the U.S. since 1994, and the company opened the U.S. affiliate in January 2010. The company's U.S. offices are located in Madison, N.J.
- Has a 100+ year history as a specialty pharmaceutical company, committed to the discovery and development of novel drugs for patients.
- Markets products in 100+ countries worldwide.
- Employs 6,000 dedicated colleagues operating across 61 countries.
- Remains wholly owned by The LEO Foundation and is headquartered in Ballerup, Denmark, outside Copenhagen.
Learn more about Our Pioneering Story.
Our Mission and Vision
Click to enlarge Our Values
LEO Pharma is owned in full by the LEO Foundation, independent of outside capital. The LEO Foundation is one of Denmark’s largest commercial foundations. Established in 1984, the LEO Foundation’s main objective is to ensure LEO Pharma’s long-term independence and success as a global, research-based pharmaceutical company. The LEO Foundation is the sole shareholder of LEO Pharma and is independent from heirs, outside shareholders, and other interests.